Ads
related to: enbrel psoriasis before and after- Dosing & Administration
Learn How Treatment is Administered
and Find Dosing Information.
- Support & Resources
Learn How Patients May Acquire
ILUMYA® at Low or No-Cost.
- ILUMYA® Resources
Find Resources to Support Your
Patients and Your Practice.
- See How ILUMYA® Works
View 5-Year Data & Explore the
Durable Safety Profile of ILUMYA®.
- ILUMYA® Case Studies
View Real-World Case Studies & See
Real ILUMYA® Patient Results.
- Patient Safety Outcomes
Learn about ILUMYA® Baseline Trial
Demographics with Various Patients.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Etanercept, sold under the brand name Enbrel among others, is a biologic medical product that is used to treat autoimmune diseases by interfering with tumor necrosis factor (TNF), a soluble inflammatory cytokine, by acting as a TNF inhibitor.
A TNF-α (tumor necrosis factor-alpha) binding protein is a monoclonal antibody or a circulating receptor such as infliximab (Remicade), etanercept (Enbrel), or adalimumab (Humira) that binds to TNF-α, preventing it from inducing the synthesis of IL-1 and IL-6 and the adhesion of lymphocyte-activating molecules.
Psoriatic arthritis tends to appear about 10 years after the first signs of psoriasis. [3] For the majority of people, this is between the ages of 30 and 55, but the disease can also affect children. The onset of psoriatic arthritis symptoms before symptoms of skin psoriasis is more common in children than adults. [48]
Psoriasis occurs when a person’s immune system incorrectly signals the skin cells to produce new cells too quickly. This causes an excess in skin cells that cause patches and scabs.
Telling the difference between psoriasis and eczema can be tough if you don't know what to look for. Expert dermatologists say these characteristics can help you identify these skin conditions.
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: enbrel psoriasis before and after